FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes
pharmaceutical investing Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business Update
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides a Business Update
Steadright Removes Titanbeach One Technical Report And Retains Qualified Geologist For New Technical Report
The Metal You've Never Heard Of Is Becoming a National-Security Priority -- and America Barely Mines It
